SM
Steven J Mento
Director

Steven J Mento insider trades: Sangamo Therapeutics (SGMO) stock buys and sales

Director, Sangamo Therapeutics Last trade Apr 2, 2018 46 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2007
4
Companies
last trade 2018

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Steven reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Apr 2, 2018SGMO↓ Sell$133K
Mar 1, 2018SGMO↓ Sell$220K
Feb 1, 2018SGMO↓ Sell$237K
Mar 5, 2015SGMO↓ Sell$119K
Dec 11, 2014SGMO↓ Sell$95K
Jun 9, 2014SGMO↓ Sell$65K
Mar 14, 2014SGMO↓ Sell$139K
Jul 30, 2013CNAT↑ Buy$152K
Nov 15, 2007SGMO↓ Sell$221K
Nov 14, 2007SGMO↓ Sell$290K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other SGMO insiders

Open-market trades in the last 12 months

About Steven J Mento's insider trades

Steven J Mento is a director at Sangamo Therapeutics (SGMO). Since Nov 14, 2007, Steven has reported 1 open-market purchase worth $152K and 9 sales worth $1.5M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (30 filings), option exercises (12 filings), shares returned to the company (3 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SGMO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.